Building better AI for healthcare with synthetic data

At Aindo, we develop tools that help researchers, hospitals, and healthcare innovators work with data that is safe, shareable, and scientifically robust. This blog is the first in our Synthetic Data in Healthcare series, where we explore how synthetic data is transforming the field.

AI in healthcare

Artificial Intelligence is rapidly transforming healthcare – from diagnostic imaging to patient triage, drug discovery to personalized medicine. But AI is only as good as the data it learns from. And in healthcare, access to rich, diverse, and compliant data is one of the biggest roadblocks to innovation.

Why AI in healthcare needs better data

Training reliable AI systems requires large volumes of high-quality data that represent real-world variability across:

• diseases and comorbidities,
• patient demographics,
• treatment pathways,
• outcomes over time.

Yet in practice, healthcare data is often:

• Fragmented: spread across institutions, regions, and systems.
• Sensitive: tightly restricted under GDPR and other privacy regulations.
• Imbalanced: skewed toward common conditions or dominant groups.

This makes it difficult for researchers and innovators to access the data they need, when they need it. Industry research suggests that data-intensive projects in healthcare take an average of nine months to complete,¹ with patient recruitment alone accounting for up to 30% of clinical trial costs.² The result is slow progress, high costs, and models that may not generalize well across diverse patient populations.

Synthetic data: fuel for healthcare AI

Synthetic data changes this.

Generated by advanced generative AI models, synthetic data replicates the statistical properties of real data without exposing individual patients. When validated for quality and privacy, it becomes a powerful enabler for AI development: safe to use, fast to access, and free to share across teams and borders.

With synthetic data, healthcare innovators can:

• Accelerate AI development with ready-to-use, privacy-safe datasets that bypass long approval processes.
• Expand coverage and fairness by rebalancing data across age, gender, ethnicity, and rare conditions.
• Test edge cases with synthetic data that realistically represents rare diseases or underrepresented cohorts.
• Facilitate secure collaboration through compliant data sharing across teams, institutions, and borders.
• Improve real-world performance by enriching training datasets for stronger model generalization.

Why it matters

Synthetic data makes it possible for healthcare AI to advance without compromise: protecting individuals while unlocking insights at scale.

For patients, this means quicker development of diagnostic tools, safer treatment recommendations, and more inclusive AI systems that perform well across diverse populations. For innovators, it means reduced delays, lower costs, and a more direct path from research to real-world impact.

What’s next

In our next blog in the Synthetic Data in Healthcare series, we will explore how synthetic data powers Real-World Evidence (RWE), helping researchers generate credible insights when traditional data is scarce or inaccessible.

In the meantime, you can dive deeper by checking out our white paper on synthetic data in clinical research.

Curious how synthetic data could accelerate your next AI project? Let’s talk about your use case today.

Footnotes

1. “Gartner Identifies Four Trends Driving Near-Term Artificial Intelligence Innovation.” Gartner, 2021. ↩

2. Deloitte Insights. “Intelligent clinical trials: Transforming through AI-enabled engagement.” Deloitte, 2020. ↩